TELA Bio, Inc. (TELA) Shareholder/Analyst Call Transcript

TELA Bio, Inc. held a shareholder/analyst call to discuss its third quarter 2026 results. The company reported a net loss of $0.14 per share, narrower than the expected $0.16 loss.

TELA Bio's CEO discussed the company's progress in its tissue repair and regeneration business.